WallStreetZenWallStreetZen

NASDAQ: FBLG
Fibrobiologics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FBLG

Based on 2 analysts offering 12 month price targets for Fibrobiologics Inc

Min Forecast
$12.00+1,383.31%
Avg Forecast
$14.00+1,630.53%
Max Forecast
$16.00+1,877.75%

Should I buy or sell FBLG stock?

Based on 2 analysts offering ratings for Fibrobiologics Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although FBLG's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates FBLG as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their FBLG stock forecasts and price targets.

FBLG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-15
lockedlocked$00.00+00.00%2025-04-01

1 of 1

Forecast return on equity

Is FBLG forecast to generate an efficient return?

Company
-1,367.68%
Industry
140.86%
Market
89.98%
FBLG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is FBLG forecast to generate an efficient return on assets?

Company
-281.29%
Industry
32.43%
FBLG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FBLG earnings per share forecast

What is FBLG's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.45
Avg 2 year Forecast
-$0.46
Avg 3 year Forecast
-$0.56

FBLG revenue forecast

What is FBLG's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$14.9M
Avg 2 year Forecast
$37.9M
Avg 3 year Forecast
$77.3M

FBLG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FBLG$0.81$14.00+1,630.53%Strong Buy
CAMP$1.54$8.00+419.48%Buy
RANI$0.53$7.75+1,376.19%Strong Buy
ABVC$1.77N/AN/A
ANTX$1.07$2.00+86.92%Buy
View Top Biotech Stocks

Fibrobiologics Stock Forecast FAQ

Is Fibrobiologics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: FBLG) stock is to Strong Buy FBLG stock.

Out of 2 analysts, 1 (50%) are recommending FBLG as a Strong Buy, 1 (50%) are recommending FBLG as a Buy, 0 (0%) are recommending FBLG as a Hold, 0 (0%) are recommending FBLG as a Sell, and 0 (0%) are recommending FBLG as a Strong Sell.

If you're new to stock investing, here's how to buy Fibrobiologics stock.

What is FBLG's earnings growth forecast for 2025-2027?

(NASDAQ: FBLG) Fibrobiologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Fibrobiologics's earnings in 2025 is -$7,667,000.On average, 2 Wall Street analysts forecast FBLG's earnings for 2025 to be -$17,026,851, with the lowest FBLG earnings forecast at -$18,748,667, and the highest FBLG earnings forecast at -$15,305,034. On average, 2 Wall Street analysts forecast FBLG's earnings for 2026 to be -$17,409,477, with the lowest FBLG earnings forecast at -$22,957,552, and the highest FBLG earnings forecast at -$11,861,402.

In 2027, FBLG is forecast to generate -$21,427,048 in earnings, with the lowest earnings forecast at -$30,992,695 and the highest earnings forecast at -$11,861,402.

What is FBLG's revenue growth forecast for 2028-2030?

(NASDAQ: FBLG) Fibrobiologics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.57%.

Fibrobiologics's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast FBLG's revenue for 2028 to be $570,877,783, with the lowest FBLG revenue forecast at $570,877,783, and the highest FBLG revenue forecast at $570,877,783. On average, 1 Wall Street analysts forecast FBLG's revenue for 2029 to be $1,449,769,384, with the lowest FBLG revenue forecast at $1,449,769,384, and the highest FBLG revenue forecast at $1,449,769,384.

In 2030, FBLG is forecast to generate $2,958,080,524 in revenue, with the lowest revenue forecast at $2,958,080,524 and the highest revenue forecast at $2,958,080,524.

What is FBLG's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: FBLG) forecast ROA is -281.29%, which is lower than the forecast US Biotechnology industry average of 32.43%.

What is FBLG's Price Target?

According to 2 Wall Street analysts that have issued a 1 year FBLG price target, the average FBLG price target is $14.00, with the highest FBLG stock price forecast at $16.00 and the lowest FBLG stock price forecast at $12.00.

On average, Wall Street analysts predict that Fibrobiologics's share price could reach $14.00 by May 15, 2026. The average Fibrobiologics stock price prediction forecasts a potential upside of 1,630.53% from the current FBLG share price of $0.81.

What is FBLG's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: FBLG) Fibrobiologics's current Earnings Per Share (EPS) is -$0.21. On average, analysts forecast that FBLG's EPS will be -$0.45 for 2025, with the lowest EPS forecast at -$0.49, and the highest EPS forecast at -$0.40. On average, analysts forecast that FBLG's EPS will be -$0.46 for 2026, with the lowest EPS forecast at -$0.60, and the highest EPS forecast at -$0.31. In 2027, FBLG's EPS is forecast to hit -$0.56 (min: -$0.81, max: -$0.31).

What is FBLG's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: FBLG) forecast ROE is -1,367.68%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.